SCIENTIFIC PAPERS
1. Walker PP, Pompilio PP, Zanaboni P, et al. Telemonitoring in Chronic Obstructive Pulmonary Disease (CHROMED). A Randomized Clinical Trial. Am J Respir Crit Care Med. 2018;198(5):620-628. doi:10.1164/rccm.201712-2404OC
2. Gobbi A, Milesi I, Govoni L, Pedotti A, Dellacà RL. A New Telemedicine System for the Home Monitoring of Lung Function in Patients with Obstructive Respiratory Diseases. 2009 Int Conf eHealth, Telemedicine, Soc Med. February 2009:117-122. doi:10.1109/eTELEMED.2009.18
3. Zimmermann SC, Huvanandana J, Nguyen CD, et al. Day-to-day variability of forced oscillatory mechanics for early detection of acute exacerbations in COPD. Eur Respir J. 2020;56(3). doi:10.1183/13993003.01739-2019
4. Gobbi A, Gulotta C, Suki B, et al. Monitoring of respiratory resistance in the diagnosis of mild-intermittent asthma. Clin Exp Allergy. 2019:0-1. doi:10.1111/cea.13376
5. Gobbi A, Dellacá RL, King G, Thamrin C. Toward Predicting Individual Risk in Asthma Using Daily Home Monitoring of Resistance. Am J Respir Crit Care Med. 2017;195(2):265-267. doi:10.1164/rccm.201603-0537LE
RESTECH srl and VIVISOL has established a long-term commercial partnership to commercialize the RESMON PRO DIARY and its innovative algorithm for the detection of the risk of exacerbation in COPD patients. Thanks to this collaboration RESTECH will be able to consolidate its operative know-how and bring the latest innovations in home monitoring directly in the homes of COPD patients of the main countries of Europe.